2007Chinese Journal of Hospital PharmacyRequires access

Study on bioequivalence of domestic ambroxol hydrochloride orally disintegrating tablets and imported tablets in Chinese healthy volunteers

Cui Ma

Open publisher page 0 citations

Abstract

OBJECTIVE To study the bioequivalence of ambroxol hydrochloride orally disintegrating tablets in Chinese healthy volunteers.METHODS 90 mg test preparation and reference preparation were given to 20 male healthy volunteers in randomized two-way crossover design for the pharmacokinetic and relative bioavailability study.Plasma concentrations of ambroxol were determined by HPLC-MS/MS.RESULTS The main pharmacokinetic parameters of the two preparation were:Cmax(175.6±57.3)μg·L-1 and(173.6±50.7)μg·L-1,tmax(1.3±0.3) h and(1.3±0.4)h,AUC0-24(772.1±275.3)μg·L-1·h and(760.3±205.7)μg·L-1·h,AUC0-∞(862.5±300.8)μg·L-1·h and(839.9±241.5)μg·L-1·h,t1/2(ke)(6.8±2.6)and(6.5±2.9) h,respectively.The mean relative bioavailability of test preparation vs reference preparation were(100.3±16.5)%.CONCLUSION The statistical analysis shows that the two preparations are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To study the bioequivalence of ambroxol hydrochloride orally disintegrating tablets in Chinese healthy volunteers.METHODS 90 mg test preparation and reference preparation were given to 20 male healthy volunteers in randomized two-way crossover design for the pharmacokinetic and relative bioavailability study.Plasma concentrations of ambroxol were determined by HPLC-MS/MS.RESULTS The main pharmacokinetic parameters of the two preparation were:Cmax(175.6±57.3)μg·L-1 and(173.6±50.7)μg·L-1,tmax(1.3±0.3) h and(1.3±0.4)h,AUC0-24(772.1±275.3)μg·L-1·h and(760.3±205.7)μg·L-1·h,AUC0-∞(862.5±300.8)μg·L-1·h and(839.9±241.5)μg·L-1·h,t1/2(ke)(6.8±2.6)and(6.5±2.9) h,respectively.The mean relative bioavailability of test preparation vs reference preparation were(100.3±16.5)%.CONCLUSION The statistical analysis shows that the two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the bioequivalence of ambroxol hydrochloride orally disintegrating tablets in Chinese healthy volunteers.METHODS 90 mg test preparation and reference preparation were given to 20 male healthy volunteers in randomized two-way crossover design for the pharmacokinetic and relative bioavailability study.Plasma concentrations of ambroxol were determined by HPLC-MS/MS.RESULTS The main pharmacokinetic parameters of the two preparation were:Cmax(175.6±57.3)μg·L-1 and(173.6±50.7)μg·L-1,tmax(1.3±0.3) h and(1.3±0.4)h,AUC0-24(772.1±275.3)μg·L-1·h and(760.3±205.7)μg·L-1·h,AUC0-∞(862.5±300.8)μg·L-1·h and(839.9±241.5)μg·L-1·h,t1/2(ke)(6.8±2.6)and(6.5±2.9) h,respectively.The mean relative bioavailability of test preparation vs reference preparation were(100.3±16.5)%.CONCLUSION The statistical analysis shows that the two preparations are bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Cmax, Ambroxol, Pharmacokinetics, Pharmacology, Crossover study, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on bioequivalence of domestic ambroxol hydrochloride orally disintegrating tablets and imported tablets in Chinese healthy volunteers — Research Paper | ScholarLens